Trexall
{'content': [{'@styleCode': 'bold', 'content': {'@styleCode': 'bold', 'sup': '®', '#text': 'These highlights do not include all the information needed to use TREXALL safely and effectively. See full prescribing information for TREXALL.'}}, {'@styleCode': 'bold', 'content': {'@styleCode': 'bold', 'sup': '®', '#text': 'TREXALL (methotrexate tablets), for oral use'}}, {'@styleCode': 'bold', 'content': {'@styleCode': 'bold', '#text': 'Initial U.S. Approval: 1953'}}], 'br': [None, None, None]}
e942f8db-510f-44d6-acb5-b822196f5e8c
HUMAN PRESCRIPTION DRUG LABEL
Apr 30, 2021
Teva Women's Health, Inc.
DUNS: 017038951
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
Methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Methotrexate
Product Details
FDA regulatory identification and product classification information